SOLVENTUM CORP (SOLV) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:SOLV • US83444M1018

78.12 USD
+1.14 (+1.48%)
At close: Feb 6, 2026
78.12 USD
0 (0%)
After Hours: 2/6/2026, 8:06:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SOLV. SOLV was compared to 186 industry peers in the Health Care Equipment & Supplies industry. While SOLV is still in line with the averages on profitability rating, there are concerns on its financial health. SOLV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • SOLV had positive earnings in the past year.
  • SOLV had a positive operating cash flow in the past year.
SOLV Yearly Net Income VS EBIT VS OCF VS FCFSOLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

  • SOLV has a better Return On Assets (10.91%) than 95.16% of its industry peers.
  • With an excellent Return On Equity value of 30.57%, SOLV belongs to the best of the industry, outperforming 98.92% of the companies in the same industry.
  • The Return On Invested Capital of SOLV (5.13%) is better than 77.42% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SOLV is in line with the industry average of 8.80%.
  • The last Return On Invested Capital (5.13%) for SOLV is well below the 3 year average (9.85%), which needs to be investigated, but indicates that SOLV had better years and this may not be a problem.
Industry RankSector Rank
ROA 10.91%
ROE 30.57%
ROIC 5.13%
ROA(3y)7.62%
ROA(5y)N/A
ROE(3y)13.05%
ROE(5y)N/A
ROIC(3y)9.85%
ROIC(5y)N/A
SOLV Yearly ROA, ROE, ROICSOLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 18.14%, SOLV belongs to the best of the industry, outperforming 94.09% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SOLV has declined.
  • SOLV has a better Operating Margin (8.44%) than 76.34% of its industry peers.
  • SOLV's Operating Margin has declined in the last couple of years.
  • SOLV's Gross Margin of 54.18% is in line compared to the rest of the industry. SOLV outperforms 51.08% of its industry peers.
  • SOLV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.44%
PM (TTM) 18.14%
GM 54.18%
OM growth 3Y-16.68%
OM growth 5YN/A
PM growth 3Y-31.26%
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5YN/A
SOLV Yearly Profit, Operating, Gross MarginsSOLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SOLV is destroying value.
  • SOLV has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, SOLV has a worse debt to assets ratio.
SOLV Yearly Shares OutstandingSOLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
SOLV Yearly Total Debt VS Total AssetsSOLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5B 10B

2.2 Solvency

  • SOLV has an Altman-Z score of 1.97. This is not the best score and indicates that SOLV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • SOLV has a better Altman-Z score (1.97) than 61.29% of its industry peers.
  • SOLV has a debt to FCF ratio of 102.74. This is a negative value and a sign of low solvency as SOLV would need 102.74 years to pay back of all of its debts.
  • SOLV has a better Debt to FCF ratio (102.74) than 66.67% of its industry peers.
  • SOLV has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of SOLV (1.03) is worse than 75.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 102.74
Altman-Z 1.97
ROIC/WACC0.51
WACC10.15%
SOLV Yearly LT Debt VS Equity VS FCFSOLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.50 indicates that SOLV should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.50, SOLV is doing worse than 73.66% of the companies in the same industry.
  • A Quick Ratio of 1.14 indicates that SOLV should not have too much problems paying its short term obligations.
  • SOLV has a Quick ratio of 1.14. This is in the lower half of the industry: SOLV underperforms 69.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.14
SOLV Yearly Current Assets VS Current LiabilitesSOLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • SOLV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 108.76%, which is quite impressive.
  • SOLV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.19% yearly.
  • SOLV shows a small growth in Revenue. In the last year, the Revenue has grown by 2.28%.
  • SOLV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.34% yearly.
EPS 1Y (TTM)108.76%
EPS 3Y-31.19%
EPS 5YN/A
EPS Q2Q%-8.54%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y0.34%
Revenue growth 5YN/A
Sales Q2Q%0.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.39% on average over the next years.
  • Based on estimates for the next years, SOLV will show a small growth in Revenue. The Revenue will grow by 0.73% on average per year.
EPS Next Y-8.14%
EPS Next 2Y-1.62%
EPS Next 3Y1.71%
EPS Next 5Y4.39%
Revenue Next Year0.54%
Revenue Next 2Y-1.35%
Revenue Next 3Y0.17%
Revenue Next 5Y0.73%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOLV Yearly Revenue VS EstimatesSOLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
SOLV Yearly EPS VS EstimatesSOLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.15, the valuation of SOLV can be described as correct.
  • Based on the Price/Earnings ratio, SOLV is valued cheaply inside the industry as 91.94% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of SOLV to the average of the S&P500 Index (27.93), we can say SOLV is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 12.07, the valuation of SOLV can be described as correct.
  • Based on the Price/Forward Earnings ratio, SOLV is valued cheaply inside the industry as 92.47% of the companies are valued more expensively.
  • SOLV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.77.
Industry RankSector Rank
PE 13.15
Fwd PE 12.07
SOLV Price Earnings VS Forward Price EarningsSOLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • SOLV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SOLV is cheaper than 84.95% of the companies in the same industry.
  • SOLV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SOLV is cheaper than 67.20% of the companies in the same industry.
Industry RankSector Rank
P/FCF 271
EV/EBITDA 13.85
SOLV Per share dataSOLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.62%
EPS Next 3Y1.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SOLV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SOLVENTUM CORP

NYSE:SOLV (2/6/2026, 8:06:44 PM)

After market: 78.12 0 (0%)

78.12

+1.14 (+1.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners72.36%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner Change-33.75%
Market Cap13.55B
Revenue(TTM)8.40B
Net Income(TTM)1.52B
Analysts74.29
Price Target91.16 (16.69%)
Short Float %2.48%
Short Ratio3.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.87%
Min EPS beat(2)2.66%
Max EPS beat(2)15.09%
EPS beat(4)4
Avg EPS beat(4)7.48%
Min EPS beat(4)2.66%
Max EPS beat(4)15.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.07%
Min Revenue beat(2)-0.05%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)0%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)0.68%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.61%
PT rev (3m)4.76%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)0.06%
EPS NY rev (1m)0.03%
EPS NY rev (3m)1.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 13.15
Fwd PE 12.07
P/S 1.61
P/FCF 271
P/OCF 27.48
P/B 2.72
P/tB N/A
EV/EBITDA 13.85
EPS(TTM)5.94
EY7.6%
EPS(NY)6.47
Fwd EY8.29%
FCF(TTM)0.29
FCFY0.37%
OCF(TTM)2.84
OCFY3.64%
SpS48.44
BVpS28.75
TBVpS-14.4
PEG (NY)N/A
PEG (5Y)N/A
Graham Number61.98
Profitability
Industry RankSector Rank
ROA 10.91%
ROE 30.57%
ROCE 6.43%
ROIC 5.13%
ROICexc 6.03%
ROICexgc 29.65%
OM 8.44%
PM (TTM) 18.14%
GM 54.18%
FCFM 0.6%
ROA(3y)7.62%
ROA(5y)N/A
ROE(3y)13.05%
ROE(5y)N/A
ROIC(3y)9.85%
ROIC(5y)N/A
ROICexc(3y)10.1%
ROICexc(5y)N/A
ROICexgc(3y)49.33%
ROICexgc(5y)N/A
ROCE(3y)12.33%
ROCE(5y)N/A
ROICexgc growth 3Y-14.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.55%
ROICexc growth 5YN/A
OM growth 3Y-16.68%
OM growth 5YN/A
PM growth 3Y-31.26%
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5YN/A
F-Score6
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 102.74
Debt/EBITDA 4.17
Cap/Depr 84.87%
Cap/Sales 5.27%
Interest Coverage 250
Cash Conversion 40.05%
Profit Quality 3.28%
Current Ratio 1.5
Quick Ratio 1.14
Altman-Z 1.97
F-Score6
WACC10.15%
ROIC/WACC0.51
Cap/Depr(3y)54.53%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.74%
Cap/Sales(5y)N/A
Profit Quality(3y)131.71%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.76%
EPS 3Y-31.19%
EPS 5YN/A
EPS Q2Q%-8.54%
EPS Next Y-8.14%
EPS Next 2Y-1.62%
EPS Next 3Y1.71%
EPS Next 5Y4.39%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y0.34%
Revenue growth 5YN/A
Sales Q2Q%0.67%
Revenue Next Year0.54%
Revenue Next 2Y-1.35%
Revenue Next 3Y0.17%
Revenue Next 5Y0.73%
EBIT growth 1Y-45.71%
EBIT growth 3Y-16.4%
EBIT growth 5YN/A
EBIT Next Year17.61%
EBIT Next 3Y6.96%
EBIT Next 5Y3.32%
FCF growth 1Y-50.46%
FCF growth 3Y-25.22%
FCF growth 5YN/A
OCF growth 1Y-38.12%
OCF growth 3Y-18.66%
OCF growth 5YN/A

SOLVENTUM CORP / SOLV FAQ

Can you provide the ChartMill fundamental rating for SOLVENTUM CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.


What is the valuation status of SOLVENTUM CORP (SOLV) stock?

ChartMill assigns a valuation rating of 6 / 10 to SOLVENTUM CORP (SOLV). This can be considered as Fairly Valued.


Can you provide the profitability details for SOLVENTUM CORP?

SOLVENTUM CORP (SOLV) has a profitability rating of 5 / 10.


How financially healthy is SOLVENTUM CORP?

The financial health rating of SOLVENTUM CORP (SOLV) is 3 / 10.